Evidence map›Paper›PMID 35416965›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Diagnosis and Management of Uncomplicated Chlamydia trachomatis Infections in Adolescents and Adults: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.

William M Geisler, Jane S Hocking, Toni Darville, Byron E Batteiger, Robert C Brunham

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Inclusion Membrane Proteins ofMicroorganisms · 2026
    Review
  2. Article
  3. Article
  4. Sexually Transmitted Infections in People with Human Immunodeficiency Virus.Infectious disease clinics of North America · 2024
    Review
  5. Review
  6. Extra Virgin Olive Oil-Based Formulations: A "Green" Strategy againstInternational journal of molecular sciences · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

William M GeislerDivision of Infectious Diseases, Department of Medicine and Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jane S HockingCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
Toni DarvilleDepartment of Pediatrics and Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Byron E BatteigerDepartment of Medicine and Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Robert C BrunhamVaccine Research Laboratory, University of British Columbia Centre for Disease Control, Vancouver, Canada.
BC Centre for Disease Control · CAIndiana University School of MedicineThe University of Melbourne · AUUniversity of Alabama at Birmingham · USUniversity of North Carolina at Chapel Hill · US

Funding

University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)U19AI144181 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI O'CONNELL, CATHERINE MARY · 2019 to 2023
$10.7M
Natural Immunity Against Chlamydia trachomatisR01AI119164 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI · 2016 to 2020
$3.6M
ALABAMA/NORTH CAROLINA STD/HIV PREVENTION TRAINING CENTER COMPONENT AU62PS004582 · PS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HOOK, EDWARD W · 2014 to 2015
$490k
NCHHSTP CDC HHS U62 PS004582NIAID NIH HHS R01 AI119164NIAID NIH HHS U19 AI144181
6 · The paper itself

Abstract

To prepare for the development of the 2021 Centers for Disease Control and Prevention (CDC) sexually transmitted infections treatment guidelines, the CDC convened a committee of expert consultants in June 2019 to discuss recent abstracts and published literature on the epidemiology, diagnosis, and management of sexually transmitted infections.This paper summarizes the key questions, evidence, and recommendations for the diagnosis and management of uncomplicated Chlamydia trachomatis (CT) infections in adolescents and adults that were reviewed and discussed for consideration in developing the guidelines. The evidence reviewed mostly focused on efficacy of doxycycline and azithromycin for urogenital, rectal, and oropharyngeal CT infection, CT risk factors in women, performance of CT nucleic acid amplification tests on self-collected meatal specimens in men, and performance of newer CT point-of-care tests.

Indexed as

Chlamydia InfectionsSexually Transmitted DiseasesAdolescentAdultAzithromycinCenters for Disease Control and Prevention, U.S.Chlamydia trachomatisFemaleHumansMaleUnited StatesAzithromycinCDCchlamydiadiagnosisguidelinesmanagementscreeningtreatment

Identifiers

PMID35416965
PMCPMC9006972
OpenAlexW4211020822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.